FTC Sharpens Consent Order Language In Wake Of LaneLabs Ruling
This article was originally published in The Tan Sheet
Executive Summary
A legal setback for the Federal Trade Commission likely means more explicit prohibitions in future agency actions against health claims
You may also be interested in...
LaneLabs Harnesses Science, Expert Support To Prevail Over FTC
A supplement firm's victory over the Federal Trade Commission in federal court demonstrates the rigorous expert support and claim substantiation necessary for thwarting legal challenges from regulators
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands